Brad Hively - 13 Nov 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: Director
Signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Issuer symbol: TOI
Transactions as of: 13 Nov 2023
Net transactions value: -$143,386
Form type: 4
Filing time: 15 Nov 2023, 18:49:28 UTC
Previous filing: 21 Mar 2023
Next filing: 21 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	TOI	Common stock	Options Exercise	$39,950	+47,000	+6.5%	$0.8500	771,182	13 Nov 2023	Direct
transaction	TOI	Common stock	Sale	$118,581	-47,000	-6.1%	$2.52	724,182	13 Nov 2023	Direct
transaction	TOI	Common stock	Disposed to Issuer	$64,755	-27,117	-3.7%	$2.39	697,065	14 Nov 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-47,000	-2.6%	$0.000000	1,770,431	13 Nov 2023	Common stock	47,000	$0.8500	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of December 2, 2019 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.

Content

These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of December 2, 2019 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.